EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy, and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays, ELISAs, immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA), molecular genetic test systems, and automation technologies.
+49 451 2032-0
View All Product News
ClinicalReal-time PCR test for specific detection of SARS-CoV-2, including the variants alpha (B.1.1.7 lineage), beta (B.1.351 lineage), gamma (P.1 lineage) and delta (B1.617.2 lineage)
ClinicalQuantitative ELISA for determination of the concentration of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2
ClinicalSurrogate virus neutralisation test (sVNT) for determination of neutralising antibodies that inhibit the binding of SARS-CoV-2 S1/RBD to ACE2 receptors
ClinicalSet containing all materials required for collection of dried blood spot (DBS) samples and subsequent dispatch to a diagnostic laboratory for analysis of anti-SARS-CoV-2 IgG antibodies. The antibody detection is performed using EUROIMMUN ELISAs such as the Anti-SARS-CoV-2 QuantiVac ELISA (IgG), which provides quantitative measurement of IgG antibodies directed against
ClinicalThe Quan T-Cell ELISA used in combination with the Quan-T-Cell SARS-CoV-2 is an interferon-gamma release assay (IGRA) for quantitative determination of the IFN-γ release of SARS-CoV-2-specific T cells.